Formosa Pharmaceuticals Partners with Saval Corporation to Advance Innovative Ophthalmic Treatment Formosa Pharmaceuticals has secured an exclusive licensing deal with Saval Corporation for a groundbreaking ophthalmic suspension, set to revolutionize post-operative care.

Formosa Pharmaceuticals Partners with Saval Corporation to Advance Innovative Ophthalmic Treatment #Taiwan #Taipei #Formosa_Pharmaceuticals #Clobetasol_Propionate #Saval_Corporation